Resection or Ablation of Small Kidney Tumors

Ablative treatments are believed to have a lower rate of complications, shorter hospital stays, and fewer interventions with benign PAD compared to partial nephrectomies in small kidney cancer lesions. The purpose of the study is to compare complications, the frequency of residual tumors, impact on kidney function, differences in quality of life, and health economic factors in a randomised study. We will also compare the oncological outcomes, including survival and recurrence of kidney cancer.

NCT Number	NCT06278506
Lead Sponsor	Karolinska University Hospital
Conditions	Kidney Cancer
Enrollment	300 participants
Start Date	2024-01-31
Primary Completion	2027-12 (estimated)
Study Completion	2037-12 (estimated)
Updated on ClinicalTrials.gov	2024-02-26